Lixte Biotechnology Stock (NASDAQ: LIXT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 52.33K |
Day Range | - - - |
52 Wk Range | 1.55 - 4.42 |
Market Cap | $4.14M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 1.42% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lixte Biotechnology (NASDAQ:LIXT) through any online brokerage.
Other companies in Lixte Biotechnology’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), Trevena (NASDAQ:TRVN) and AquaBounty Techs (NASDAQ:AQB).
There is no analysis for Lixte Biotechnology to provide a consensus price target.
The stock price for Lixte Biotechnology (NASDAQ: LIXT) is $1.84 last updated September 23, 2024 at 3:59 PM EDT.
There are no upcoming dividends for Lixte Biotechnology.
Lixte Biotechnology’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Lixte Biotechnology.
Lixte Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.